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Abstract 1 
Purpose 2 
To assess the performance of Patient Reported Outcome Measure (PROM) 3 
questionnaires toand determine their appropriateness for routine use in 4 
cataract patients.   5 
Setting 6 
Moorfields Eye Hospital, London, United Kingdom.  7 
Design 8 
Prospective cohort study. 9 
Method 10 
Patients undergoing cataract surgery between February and March 2013 11 
were recruited. Four questionnaires, including Catquest-9SF, EQ-5D and its 12 
visual analog scale (VAS), NEI-SES and VF-8R were given to patients to 13 
complete before surgery, 3 weeks post-surgery and 3 months post-surgery. 14 
Rasch-analyzed data, when possible, was used to compare questionnaires’ 15 
performances. Statistical significance was calculated with paired student’s t-16 
test. Pearson’s correlation coefficients were determined between PROMs’ 17 
scores and visual acuity.  18 
 19 
 20 
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Results 21 
Among the 1223 patients recruited, 675.29% and 61.8% completed 3 weeks 22 
and 3 months follow-up respectively. Changes in mean scores for Catquest-23 
9SF, EQ-5D, EQ-VAS, NEI-SES and VF-8R at 3 weeks were 110120.86% 24 
(p<0=.0001), 1.61-0.5% (p=0.610.77), 3.375% (p=0.098), 16.125.8% 25 
(p=0.1233) and 61.763. 2% (p<=0.00016) respectively. At 3 months, these 26 
were 16257.423% (p<0.0001), 4.542.4% (p=0.164), 4.848% (p=0.09), 27 
54.6349.1% (p<=0.00016) and 876.553% (p<0.0001), respectively. Weak 28 
correlations were found between Catquest-9SF, NEI-SES and pre-operative 29 
visual acuity. While all PROM questionnaires correlated to ;post-operative 30 
visual acuity measures, the correlations were  and between Catquest-9SF, 31 
NEI-SES, VF-8R, EQ-5D and post-operative visual acuity. variable and weak 32 
at best.  33 
 34 
Conclusion 35 
It is feasible to assess patient reported outcome in cataract surgery as routine 36 
practice. Improvements in visual function could be detected as early as 3 37 
weeks post-surgery by Catquest-9SF and VF-8R, while cataract surgery may 38 
exert a delayed effect on patient’s socioemotional construct. Visual acuity 39 
measures do not fully reflect patients’ reported visual function and cLack of 40 
correlations between PROMs and visual acuitylinicians should consider 41 
assessment of  raised the importance of assessing patient reported visual 42 
function prior to cataract surgery in order to facilitate surgical decision-making.43 
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Introduction  44 
Cataract surgery is the commonest procedure performed in the public 45 
healthcare system, the National Health Service (NHS), in the United Kingdom, 46 
with around 330 000 cases performed in England.1 Although there is clear 47 
evidence of objective visual improvements from modern cataract surgery,2 48 
based on visual acuity measurement, this fails to accurately evaluate patient 49 
perceived benefits of the procedure.3  50 
Patient-reported outcome measures (PROMs) examining health related 51 
quality of life, functional status and symptom scores have increasingly been 52 
recognized as important tools in patient centered care and in measuring the 53 
value of health interventions.A Generic PROM, measured by EQ-5D, has been 54 
a mandatory requirement for four types of high volume elective surgeries 55 
performed in NHS England, namely hip and knee replacements, groin hernia 56 
repair, and varicose vein surgery since 2009. However, dDespite the volume 57 
of cases, cataract surgery is currently not included due to uncertainties of 58 
validity and responsiveness of EQ-5D in these patients.4 59 
The 51-item National Eye Institute Visual Function Questionnaire (NEI-VFQ) 60 
is considered the ‘gold-standard’ for assessing visual function.5 A shortened 61 
version of NEI-VFQ with 25 items (NEI-VFQ-25) has also been introduced in 62 
the assessment of vision-related quality of life of patients with ocular diseases 63 
in cross-sectional studies.6-10 This Both versions have been used mainly in the 64 
has remained largely a research setting tool, as they are However, it is 65 
lengthy and time-consuming both for patients to complete and for clinicians to 66 
analyze, making them difficult to implement therefore not practical in in routine 67 
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clinical practice settings., and therefore has remained largely a research tool. 68 
NEI-VFQ was also found to contain several design issues that reduces its 69 
validity, namely multidimensionality (more than 1 construct in 1 score), 70 
questions that did not fit the construct, suboptimum targeting of item difficulty 71 
to person ability, and dysfunctional subscales.11 72 
A shortened version of NEI-VFQ with 25 items (NEI-VFQ-25) has been used 73 
more widely in the assessment of vision-related quality of life of patients with 74 
ocular diseases in cross-sectional studies.6-8 More recently, shorter validated 75 
questionnaires for cataract patients have been developed. These include VF-76 
8R and Catquest-9SF,129,103 the latter of which has been successfully adopted 77 
in Sweden since 1998 as part of the Swedish National Cataract Register and 78 
is promoted by the International Consortium for Health Outcomes 79 
Measurement for international use.11 14 In the UK,However, so far there is no 80 
consensus in the UK on a PROM for cataract surgery patients so far.   81 
The aim of this study is to evaluate the feasibility of using PROMs in routine 82 
NHS service for cataract patients in the United Kingdom, and to compare the 83 
responsiveness of different tools in order to identify the best PROM for this 84 
purpose. To our knowledge, this is the first clinical study comparing PROMs 85 
for cataract patients in the United Kingdom.  86 
 87 
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Method 88 
Study cohort 89 
This was a prospective longitudinal study of consecutive patients scheduled 90 
for cataract surgery at Moorfields Eye Hospital, London between February 91 
and March 2013. Patients were recruited during their pre-operative 92 
assessment. Eligible patients had cataracts in one or both eyes, were ≥40 93 
years of age, were scheduled to have phacoemulsification and intraocular 94 
lens implant insertion, were able to read and interpret English without 95 
translation, and could give valid consent. We excluded patients with 96 
significant visual impairment from ocular comorbidities in the eye that was to 97 
be operated upon (e.g., advanced age related macular degeneration, 98 
advanced glaucoma, uncontrolled diabetic retinopathy and maculopathy, and 99 
other conditions that carried a guarded visual prognosis after cataract 100 
surgery), and patients with psychiatric or cognitive diseases. Those with 101 
stable ocular comorbidities not causing significant visual impairment were 102 
included in this study (Table 1). 103 
The study complied with the Declaration of Helsinki and was approved as a 104 
part of service evaluation. Informed consent was obtained from all participants 105 
in this study.  106 
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Data collection 107 
A study pack with four questionnaires, consisted of Catquest-9SF, EQ-5D, 108 
NEI-SES and VF-8R was given to patients to complete. Clarifications and 109 
support were given by nursing staff if patients were unable to understand the 110 
questionnaire. In accordance with the design of all the questionnaires used, 111 
patients were instructed to consider their situation during the 2 weeks prior to 112 
the assessment only. Data from one operated eye was recorded. In second 113 
eye patients, no questionnaires were given within 2 weeks of completion of 114 
the first eye surgery.  115 
The same pack was subsequently mailed to the patients at 3 weeks and at 3 116 
months post-surgery. Questionnaire response rates were enhanced by 117 
telephone call reminders at 3 weeks and 3 months post-surgery.  118 
Clinical data for the subjects was retrieved from medical records. Data 119 
collected included past medical history, pre- and post-operative corrected 120 
distance visual acuity (CDVA) and refraction, slit-lamp biomicroscopy findings, 121 
operation report, and any intra- and post-operative complications.  122 
 123 
Patient-reported outcome measuring tool selection 124 
Four preference-based patient-reported outcome instruments were selected 125 
for this study. The 4 questionnaires were selected in order to cover 3 different 126 
areas: generic health status, disease-specific health status, and 127 
socioemotional status.  128 
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EQ-5D was used as the tool for generic health status measurement. National 129 
Institute of Clinical Excellence (NICE) and the UK Department of Health have 130 
recommended the use of this questionnaire as part of a wider comparative 131 
health-care economic analysis in other common procedures in England. It 132 
consists of 5 questions concerning subject’s self-reported health, and a visual 133 
analogue scale (EQ-VAS) that allow subjects to report their perceived overall 134 
status of general health. EQ-5D has not been recommended specifically for 135 
cataract patients,B but some recent studies have shown that it is responsive in 136 
patients with visual impairments, although none of them were based in 137 
primarily English-speaking patient population.12-1515-18 138 
For disease-specific measuring tool, Catquest-9SF and VF-8R were selected. 139 
Both questionnaires were specifically designed to capture visual function data 140 
in cataract patients, and have previously been vigorously validated in English-141 
speaking populations.9,1012,13 Furthermore, a head-to-head study has shown 142 
that Catquest-9SF to be superior to other questionnaires in cataract 143 
patients.16 19 We decided to include VF-8R because its predecessor (VF-14) 144 
was recommended for UK cataract patients.B However, we did not use VF-14 145 
as it has not been Rasch-validated and is less responsive in detecting 146 
longitudinal changes in visual function.17 20  147 
NEI-SES was chosen to assess the socioemotional changes brought about by 148 
cataract surgeries. This questionnaire was based on the 39-item National Eye 149 
Institute Visual Function Questionnaire (NEI-VFQ). After validation and the 150 
removal of redundancies by Pesudovs et al., NEI-SES was developed to 151 
capture data measuring socioemotional construct.18 11  152 
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 153 
Statistical analysis  154 
Sociodemographic and clinical characteristics were analysed by descriptive 155 
statistics. Subgroup analyses on patients undergoing cataract surgery for the 156 
first time and for the second time were also performed.  157 
To assist data analysis, EQ-5D health states were converted to index values 158 
as reported previously.19,2021,22 Raw value of EQ-VAS was used, as no index 159 
score conversion was available. For Catquest-9SF, VF-8R and NEI-SES, 160 
Rasch adjusted scoring systems were preferred over summative (Likert) 161 
scoring system. The advantages of using Rasch scoring include validated 162 
scoring weighting, better precision in detecting change over time,17 20 and the 163 
possibility of using parametric statistical techniques, allowing direct 164 
comparison of the performances of the questionnaires. Rasch measuring 165 
scale is linear and uses a unit known as logit, or log-odds unit, which is the 166 
logarithm of odds ratio of the probability a person will endorse a particular 167 
rating scale step over 1- the same probability, with persons of higher ability 168 
achieving a negative score.18 11 In other words, negative logit scores 169 
represent better health states. The conversion was based on previously 170 
published articles for each questionnaire.9,10,1811-13 171 
Visual acuity was assessed by Snellen-converted ETDRS. Corrected distance 172 
visual acuity data were analyzed with ipsilateral eye undergoing surgery 173 
(CDVA), better-seeing eye (BEVA), worse-seeing eye (WEVA) and weighted 174 
average of both eyes (WVA) as separate variables of interest. The WVA was 175 
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based on 75% contribution by BEVA and 25% contribution by WEVA.2123 176 
Data analysis was performed with Microsoft Excel for Mac 2011 (Microsoft 177 
Corp, 2010). Association between continuous variables were examined using 178 
the Pearson’s correlation coefficient. Coefficients were considered strong 179 
(>0.5), moderate (>0.35 – 0.50), weak (>0.20 – 0.35), and no correlation 180 
(≤0.2). Statistical significance (P<0.05) was assessed using two-tailed paired 181 
student’s t-test after non-respondents were excluded from longitudinal data 182 
analysis.  183 
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Results 184 
One hundred and twenty-twohree patients were recruited for the study. Sixty-185 
fivefour patients (523%) were male. Mean age of all subjects (± S.D.) was 186 
70.72 ± 10.60 years. Sixty-eightnine patients (55.76.1%) had surgery on their 187 
right eye; while 67 patients (54.5*%) were undergoing cataract surgery for the 188 
first time. Forty-nineFifty-nine patients (48.40.0%) were White British and 189 
Forty-one30 (33.624.4%) were Indian. Mean pre-operative CDVA, BEVA, 190 
WEVA and WVA were 0.634±0.489, 0.267±0.2730, 0.654±0.501 and 191 
0.367±0.2730 LogMAR, respectively. Post-operative mean CDVA, BEVA, 192 
WEVA and WVA were 0.201±0.2630, 0.146±0.205, 0.357±0.358 and 193 
0.201±0.216 LogMAR, respectively. Peri-operative complications include 1 194 
case of contained anterior radial capsular tear as well as 1 case of cystoid 195 
macular oedema, 1 case of raised intraocular pressure and 1 case of post-196 
operative uveitis, all of which settled after a short course of medical treatment. 197 
Table 1 summarises the sociodemographic and clinical data.  198 
Of the 1223 patient recruited, 821 (67.25.9%) patients responded at 3 weeks 199 
after surgery, while 76 (61.8%) patients responded at 3 months after surgery. 200 
Non-respondents at each point of follow-up were excluded from further 201 
statistical analyses. Table 2 showed the median age, gender and ethnicity 202 
distribution between respondents and non-respondents at 3 weeks and at 3 203 
months. Age and gender distributions were similar between the two groups at 204 
both time points, although the ethnic groups were slightly different between 205 
respondents and non-respondents at both time points.  206 
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Patient responses at pre-operative assessment, at 3 weeks post-surgery and 207 
at 3 months post-surgery are summarized in Table 3. All questionnaires 208 
reported improvement in patient reported outcomes in relation to post-209 
operative CDVA improvement. Catquest-9SF reported the largest and 210 
statistically significant changes at both 3 weeks and 3 months post-surgery 211 
(120.8610.8%, Pp<=0.0001 and 162.4257.3%, pP<0.0001, respectively). VF-212 
8R was also statistically significant at both time points (61.76%, p<0.0001 and 213 
87.55, p<0.0001 respectively).Both VF-8R and NEI-SES reported statistically 214 
significant changes at 3 months post-surgery (86.354.63%, pP<=0.00010005 215 
and 49.1%, P=0.0006 respectively). Neither EQ-5D health states nor the EQ 216 
VAS showed change that achieved statistical significance at any time points.  217 
Figure 1 illustrates the responses from patients at both 3 weeks and at 3 218 
months post-surgery. Catquest-9SF and VF-8R showed changes that were 219 
statistically significant results at all time points. NEI-SES did not show 220 
statistically significant change in either of the patients subgroups until 3 221 
months post-operatively. Neither EQ-5D nor EQ VAS showed change that 222 
was statistically significant results at any time point. 223 
We further investigated the patients who responded to PROMs at both 3-week 224 
and 3-month post-operatively. (Table 4) Sixty-four patients responded at both 225 
time points. The changes in response to the different questionnaires were 226 
similar to those observed when all patients were considered. Significant 227 
improvements versus pre-operative responses were recorded by Catquest-228 
9SF and VF-8R at 3-weeks post-operatively. These two questionnaires and 229 
NEI-SES also registered significant improvements from pre-operative 230 
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responses at 3-months post-operatively. However, unlike Catquest-9SF and 231 
NEI-SES whose scores significantly improved between the two follow-ups, 232 
VF-8R did not register further significant improvement during this period. EQ-233 
5D and EQ-VAS did not yield noticeable changes at either time points.  234 
 235 
Subgroup analyses into the effect of first and second eye cataract surgery 236 
were performed and shown in Table 54. Catquest-9SF and VF-8R both was 237 
the only measuring tool that demonstrated statistically significant changes in 238 
both groups of patients at 3 weeks; whereas VF-8R demonstrated statistically 239 
significant change only in second eye patients at 3 weeks. Subgroup analysis 240 
of NEI-SES and EQ-5D performance in both sets of patients were similar to 241 
the overall results shown in Ffigure 1.  242 
Although considerable changes were recorded by VF-8R, these changes did 243 
not achieve statistical significance. EQ-5D and EQ-VAS did not yield 244 
noticeable changes.  245 
Table 65 illustrates the Pearson’s correlation coefficients between visual 246 
function and clinical variables. Pre-operatively, only Catquest-9SF showed 247 
weak correlation to one of the four visual function variables (WEVA, r=0.22, 248 
P<0.05). All other PROM tools did not show any correction to visual function. 249 
At 3-weeks post-surgery, Catquest-9SF, VF-8R, NEI-SES and EQ-5D were 250 
found to be weakly correlated to CDVA, BEVA and WEVA. In addition, NEI-251 
SES and EQ-5D were also weakly correlated to WVA. At 3-months post-252 
surgery, CDVA, BEVA and WVA were weakly correlated with VF-8R and NEI-253 
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SES, while WEVA was correlated to Catquest-9SF, VF-8R, NEI-SES and EQ-254 
VAS.  255 
We found no association between Catquest-9SF and either pre-operative 256 
CDVA or BEVA, and weak correlation to WEVA and WVA (Pearson’s 257 
correlation coefficients 0.18, 0.14, 0.25 and 0.22, respectively). Similarly, we 258 
found no association between NEI-SES and pre-operative CDVA and BEVA, 259 
but weak correlation to WEVA and WVA (Pearson’s correlation coefficients 260 
0.11, 0.12, 0.17 and 0.14, respectively). VF-8R, EQ-5D and EQ VAS did not 261 
appear associated with pre-operative visual function.  262 
Post-operatively, Catquest-9SF was weakly correlated to all four parameters 263 
of visual function at 3 weeks (Pearson’s correlation coefficients 0.28, 0.32, 264 
0.37 and 0.32 for CDVA, BEVA, WEVA and WVA, respectively). However, it 265 
only remained correlated to WEVA at 3 months. VF-8R was only correlated to 266 
WEVA at 3 weeks, but showed weak correlations with WEVA as well as 267 
BEVA and WVA at 3 months. NEI-SES has a similar pattern of correlation to 268 
visual function, showing weak correlations at 3 weeks to BEVA, WEVA and 269 
WVA and correlation to WEVA only at 3 months post-surgery. In contrast, EQ-270 
5D only showed weak correlation to WEVA at 3 weeks and no correlation to 271 
other parameters at any other time points. We found no evidence of 272 
association between EQ VAS and any visual function parameters at any time 273 
point.  274 
 275 
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Discussion 276 
Routine use of patient reported outcome measures could help patients and 277 
clinicians make better decisions, facilitate comparisons and stimulate 278 
improvements in the provision of healthcare.22 24 To our knowledge, this is the 279 
first clinical study evaluating different PROM tools in the same cohort of 280 
patients as part of routine cataract surgery in the UK NHS. This study showed 281 
that cataract surgery has a positive impact on visual function and is best 282 
measured by Catquest-9SF as early as 3 weeks after surgery. We also 283 
showed possible delayed improvements in the socioemotional construct in 284 
patients undergoing cataract surgery, and poor correlations between PROMs 285 
results (i.e. visual function) and clinical parameters (i.e. visual acuity) in 286 
cataract patients.  287 
Cataract surgery positively impacts visual function and therefore quality of life 288 
as determined by all the instruments in this UK population, and similar to 289 
findings from previous studieshave been reported by Desai and colleagues. 25 290 
(ref). Both Catquest-9SF and VF-8R were highly sensitive to this change, with 291 
the logit scores improved significantly by 16257% and 868% at 3 months, 292 
respectively. It has been shown previously that Catquest-9SF was the most 293 
responsive questionnaire of 16 instruments in a head-to-head study, including 294 
VF-8R in a Swedish patient cohort, (16)9 but the authors advised caution in the 295 
extrapolation of its superiority over other questionnaires to other populations. 296 
Nevertheless, oOur study lends support to the idea that Catquest-9SF is a 297 
highly responsive tool and may be the most appropriate questionnaire of 298 
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choice for the measurement of patient reported outcomes in cataract surgery 299 
in UK.  300 
Previous PROM studies have reported outcomes between 3 to 6 months after 301 
cataract surgery.9,1012,13 We purposefully chose a much earlier timeframe of 3 302 
weeks after surgery as the first point of data collection, in order to assess the 303 
feasibility of using PROMs as part of patients’ routine post-operative care, 304 
since UK patients most commonly return for their final post-operative review 305 
at 2-6 weeks either in the hospital or at their community optometrist.C By 306 
integrating PROMs with routine post-operative review, patient-reported 307 
outcomes could be collected without further patient visits or the difficulties of 308 
obtaining post-discharge questionnaire return, thereby improving patient 309 
participation rates while minimizing administrative and resource costs. 310 
At 3 weeks post-surgery, Catquest-9SF detected statistically significant 311 
improvements in visual function in patients who underwent their first cataract 312 
surgery as well as those for the second time. In contrast, at 3 weeks post-313 
surgery status, VF-8R similarly produced statistically significant responses  in 314 
both groups of patients but to a much smaller effect, especially in first eye 315 
patients at 3 weeksonly in patients who underwent second eye cataract 316 
surgery. Furthermore, we showed (Table 4) that although VF-8R responded to 317 
early improvements in patient reported visual function, it was less sensitive in 318 
capturing changes between early and later follow-up, suggesting a plateau 319 
effect of its responsiveness. These findings suggest that Catquest-9SF 320 
performance is superior to that of VF-8R, as previously shown in a head-to-321 
head comparison study.18 Our results also showed that, while improvements 322 
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in PROM could be recorded as early as 3-week post-surgery, further 323 
significant improvement could be recorded up until 3-month post-surgery. 324 
Further longer-term longitudinal study with Catquest-9SF may help 325 
demonstrate the sustainability of the PROM changes after cataract surgery. A 326 
previous study suggested that visual function improvement in patients 327 
receiving unilateral cataract surgery was dependent on whether the fellow eye 328 
has significant visual impairment (defined as CDVA ≤0.20).23 However, this is 329 
an unlikely explanation for our failure to detect an effect with VF-8R, since the 330 
majority of our first eye patients had CDVA < 0.20 in the fellow eye (42 of 63, 331 
66.7%). Visual function improvements in the first eye subgroup were 332 
statistically significant when measured by VF-8R at 3 months status-post. We 333 
therefore interpret our findings as providing evidence that Catquest-9SF 334 
captures changes of visual function at an earlier time after cataract surgery 335 
than VF-8R.  336 
 337 
A study by Shekhawat and colleagues has shown that cataract surgeries 338 
could improve patients’ socioemotional status.D Changes in socioemotional 339 
status have also been reported in cross-sectional studies involving patients 340 
undergoing other procedures, such as corneal transplants.24 However, to the 341 
best of our knowledge, longitudinal socioemotional changes have not been 342 
previously reported in cataract patients. In our study, cChanges in NEI-SES 343 
were delayed and only became were statistically significant at 3 months after 344 
cataract surgery in our study, but not earlier. These results suggest that 345 
improvement in socioemotional status occurred after improvement of visual 346 
function, and this phenomenon may not be fully assessable until at least 3 347 
Formatted: Space Before:  0 pt, After:  0 pt
Formatted: Line spacing:  Double
Page 19 
months post-operatively. Socio-emotional changes brought about by medical 348 
interventions are currently poorly understood., We speculate that 349 
neuroplasticity could account for the delayed changes in socioemotional 350 
status. Neuroplasticity is the ability of the brain to reorganise its structure and 351 
function in response to changes in the environment, and there is now a 352 
growing body of evidence that neuroplasticity occurs in adult patients with 353 
amblyopia and those after refractive surgery.26 Patients with multifocal lens 354 
also seem to display neuroplasticity or “neuroadaptation” after surgery to 355 
counteract the associated side effects, such as glare, halos and loss of 356 
contrast sensitivity, and this process can take several months. While studies 357 
of neuroplasticity in ophthalmology have focused on the visual cortex, we 358 
hypothesise that changes in other areas of the brain, including ones 359 
controlling social interactions and emotional status, also occur after cataract 360 
surgery. Since changes in socioemotional construct appeared to take longer 361 
than visual function to materialise, future research in this area should take into 362 
account the timing of data collection.  363 
In our study, EQ-5D and EQ-VAS did not respond were poorly responsive well 364 
to cataract surgery. There have been conflicting reports of validity and 365 
sensitivity of EQ-5D in patients with visual or ophthalmic related conditions.4 366 
Although There are some studies have showing n good performances of EQ-367 
5D in cataract patients, many of these which reports consist involve of patient 368 
cohorts with very different ethnic compositions compared with to our this 369 
study.12-1515-18 Our current results do not support the use of EQ-5D in routine 370 
assessment of patient reported visual function improvement after cataract 371 
surgery.  372 
Page 20 
All the questionnaires, at best, showed weak correlation with visual acuity 373 
status. Only WEVA was consistently weakly associated with Catquest-9SF 374 
and NEI-SES at all time points. Similar findings  findings have been reported 375 
noted in patients who underwent cataract surgery27 and in those with age-376 
related macular degeneration.25 28 Our study therefore adds weight to their 377 
findings and suggests that the severity of visual acuity impairment measured 378 
in clinical settings may not fully reflect patient’s visual function or their 379 
perception of the severity of their health problems. We believe , and supports 380 
the view that pre-operative assessment of patient-reported visual function and 381 
severity of deterioration could be an important tool to help assist decision-382 
making by both patients and clinicians.  383 
Limitations in this study are that it has a near 30% non-respondent rate, 384 
despite multiple telephone reminders during the study period, and raises 385 
concerns on the feasibility of routine use of PROMs. Non-respondent rates of 386 
around 50% are commonly reported in studies based on mail surveys.26 29 387 
The use of PROMs at routine post-operative visits for cataract patients would 388 
help resolve this issue. Although age and gender distribution was similar 389 
between respondents and non-respondents, there were differences in the 390 
ethnic distributions. Further work is needed to investigate any potential 391 
differences in the responses by different ethnic groups in the questionnaires 392 
we used. Furthermore, this study was based in a tertiary centre in a 393 
metropolitan area; therefore the findings may not generalize across the UK. 394 
We did not include other generic health status measuring tools due to 395 
concerns of inducing interviewee fatigue, although further studies with 396 
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different generic PROMs, such as the Health-utilities index 3 (HUI-3) may 397 
yield results that are more suitable for cost-utility analyses.  398 
In conclusion, this study demonstrated the feasibility of collecting patient-399 
reported outcomes in cataract surgery in routine clinical practice. 400 
Improvements in patient-reported visual function could be detected as early 401 
as 3 weeks post-operatively, with Catquest-9SF being the most responsive 402 
measuring tool both in first eye and second eye patients. Results from NEI-403 
SES suggest that cataract surgery could exert a delayed effect on patient’s 404 
socioemotional construct and further research in this area should be mindful 405 
of the possible bias induced by timing of data collection. Generic PROMs 406 
produce insufficient response to cataract surgery and should not be used in 407 
these patients. Visual acuity measurements correlates poorly with patient-408 
reported visual function, and the incorporation of PROMs into routine practice 409 
could assist clinical decision-making and in assessing the value of ophthalmic 410 
interventions. 411 
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What was known  412 
- Patient Reported Outcome Measures (PROMs) are important in 413 
assessing outcomes in patients undergoing medical interventions.  414 
- Previous reports have demonstrated the robustness of various PROMs 415 
in cataract surgery.  416 
What this paper adds 417 
- Catquest-9SF was shown to be the most responsive PROM tool in a 418 
British cohort at an earlier follow-up time than previously reported.  419 
- Delayed response in NEI-SES suggests a possible late effect of 420 
cataract surgery in socio-emotional construct.  421 
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Figure legends 554 
Figure 1. Box-plots of patient responses to (a) Catquest-9SF, VF-8R and NEI-555 
SES, and; (b) EQ-5D and EQ-VAS pre-operatively, at 3 week post-surgery 556 
and at 3 months post-surgery. For easier comparison, logit scores were 557 
inverted to show improvement in health states captured by Catquest-9SF, VF-558 
8R and NEI-SES. For EQ-5D, index scores were used. For EQ-VAS, 559 
percentages (in decimal) were used. Pre-operative – white; 3 weeks post-560 
surgery: dotted; 3 months post-surgery: diagonals.  561 
 562 
